Answers are grounded in this paper and cite their sources.
A new catalytic system simplifies C(sp2)–heteroatom cross-couplings, enabling gram-scale synthesis with low nickel loadings and no need for dedicated photocatalysts.
Light-mediated NiI/NiIII catalysis presents a promising alternative to thermal Pd- and Ni-catalyzed C(sp²)–heteroatom cross-couplings that operate through M0/MII mechanisms and rely on complex ligands. However, existing methods often require high nickel loadings, exhibit a limited scope, employ substrate-specific conditions, and use exogenous photocatalysts. We report a broadly applicable catalytic system that addresses these longstanding challenges through the design of a readily accessible ligand, which facilitates oxidative addition on NiI. A photocatalyst is not necessary because the applied base serves the dual role of enabling precatalyst activation with visible light and harnessing a broad range of nucleophiles, including challenging tertiary alcohols. This approach simplifies late-stage functionalization of complex molecules and enables gram-scale synthesis of pharmaceutical targets with catalyst loadings as low as 100 ppm.
No takes yet. Share an insight, caveat, or question.
Bena et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: